Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jun 4, 2010 shrotriya rajesh c md Officer Buy 10,000 3.96
Apr 19, 2010 fulmer richard Director Buy 4,000 4.83
Apr 12, 2010 Vida, Julius , PH.d. Director Buy 2,500 4.57
Apr 9, 2010 shrotriya rajesh c md Officer Buy 10,000 4.44
Feb 3, 2010 cybulski mitchell p. Director Buy 20,000 4.52
Jan 8, 2010 kumaria shyam k Officer Acquisition (Non Open Market) 10,000 n/a
Jan 8, 2010 shrotriya rajesh c md Officer Acquisition (Non Open Market) 200,000 n/a
Oct 16, 2009 shrotriya rajesh c md Officer Buy 10,000 4.57 - 4.58
Oct 14, 2009 maida anthony e iii Director Sell 21,750 4.62
Oct 14, 2009 maida anthony e iii Director Option Execute 13,000 2.55
Aug 24, 2009 Vida, Julius , PH.d. Director Buy 1,500 6.10
Jul 17, 2009 cybulski mitchell p. Director Buy 20,000 5.58
May 20, 2009 maida anthony e iii Director Buy 1,000 5.15
May 6, 2009 kumaria shyam k Officer Buy 85,000 2.70
May 6, 2009 shrotriya rajesh c md Officer Buy 290,000 2.70
May 5, 2009 shrotriya rajesh c md Officer Acquisition (Non Open Market) 10,000 2.60 - 2.65
Apr 29, 2009 shrotriya rajesh c md Officer Acquisition (Non Open Market) 50,000 2.39 - 2.45
Dec 6, 2008 kumaria shyam k Officer Acquisition (Non Open Market) 30,000 n/a
Dec 6, 2008 shrotriya rajesh c md Officer Acquisition (Non Open Market) 200,000 n/a
Nov 3, 2008 lenaz luigi md Officer Sell 5,000 1.82
Showing 201-220 of 245 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
6.09
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on May 24, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR